WO2004091522A3 - Method for treating neurodegenerative disorders - Google Patents

Method for treating neurodegenerative disorders Download PDF

Info

Publication number
WO2004091522A3
WO2004091522A3 PCT/US2004/011377 US2004011377W WO2004091522A3 WO 2004091522 A3 WO2004091522 A3 WO 2004091522A3 US 2004011377 W US2004011377 W US 2004011377W WO 2004091522 A3 WO2004091522 A3 WO 2004091522A3
Authority
WO
WIPO (PCT)
Prior art keywords
neurodegenerative disorders
treating neurodegenerative
treating
nsaid
dementia
Prior art date
Application number
PCT/US2004/011377
Other languages
French (fr)
Other versions
WO2004091522A2 (en
Inventor
Kenton Zavitz
Original Assignee
Myriad Genetics Inc
Kenton Zavitz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc, Kenton Zavitz filed Critical Myriad Genetics Inc
Publication of WO2004091522A2 publication Critical patent/WO2004091522A2/en
Publication of WO2004091522A3 publication Critical patent/WO2004091522A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides a pharmaceutical composition and a method for treating and/or preventing neurodegenerative disorders such as Alzheimer's disease, dementia, and mild cognitive impairment. In particular, the method involves administering metabolites of an NSAID to a person desiring prophylaxis against or treatment of a neurodegenerative disorder.
PCT/US2004/011377 2003-04-11 2004-04-12 Method for treating neurodegenerative disorders WO2004091522A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46224203P 2003-04-11 2003-04-11
US60/462,242 2003-04-11
US48007303P 2003-06-19 2003-06-19
US60/480,073 2003-06-19

Publications (2)

Publication Number Publication Date
WO2004091522A2 WO2004091522A2 (en) 2004-10-28
WO2004091522A3 true WO2004091522A3 (en) 2004-12-09

Family

ID=33303071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/011377 WO2004091522A2 (en) 2003-04-11 2004-04-12 Method for treating neurodegenerative disorders

Country Status (1)

Country Link
WO (1) WO2004091522A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2586436A1 (en) 2011-10-31 2013-05-01 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments

Also Published As

Publication number Publication date
WO2004091522A2 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
WO2006001877A3 (en) Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
WO2004071431A3 (en) Method and composition for treating neurodegenerative disorders
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2005067908A3 (en) Memantine for the treatment of mild and mild-to-moderate alzheimer’s disease
WO2004019863A3 (en) Combination therapy for treatment of fibrotic disorders
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2004014953A3 (en) Anti-myelin associated glycoprotein (mag) antibodies
WO2005000217A3 (en) Combination therapy for the treatment of dyslipidemia
WO2004073614A3 (en) Combination therapy for the treatment of immunoinflammatory disorders
WO2005066337A3 (en) Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
WO2001053457A3 (en) Vaccines against neurodegenerative disorders
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
WO2005092062A3 (en) Compounds for neurodegenerative disorders
IL167848A (en) Use of brimonidine in the manufacture of a medicament for treating neurodegenerative conditions
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
BG103687A (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system
WO2006020852A3 (en) Pharmaceutical composition and method for treating neurodegenerative disorders
WO2004091522A3 (en) Method for treating neurodegenerative disorders
WO2003092701A3 (en) Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
WO2004028456A3 (en) Method and composition for treating neurodegenerative disorders
WO2006020853A3 (en) Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A3 (en) Pharmaceutical composition and method for treating neurodegenerative disorders
WO2002076437A3 (en) Methods for treating neurodegenerative diseases including alzheimer's

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase